Newsmeme!
Discover News you didn't know existed
Chugai Pharmaceutical Co, Ltd announced that it filed an application with the Japanese Ministry of Health, Labour and Welfare, seeking additional approval of combination therapy with trastuzumab (genetical recombination), a humanized monoclonal antibody (brand name: Herceptin for Intravenous Infusion 60 and 150) and capecitabine, an oral fluoropyrimidine anti-cancer agent (brand name: Xeloda ...
No tags found at this time. Be the first to tag this news item, learn more.
No related news stories found.
Custom antibody development and production according to your requirement of process.: we are specialized in custom antibody development, production, monoclonal antibody production and antibody purification .With the use of latest technology and protocol we can provide you antibodies as per your requirement in just four months with best quality and in desired timeline.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |